DOACs vs Heparin in Cancer-Associated Thrombosis
Direct oral anticoagulants (DOACs) are more clinically effective and are more cost-effective for treating patients with cancer-associated thrombosis (CAT) in ...
© Medical News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.